We bring together leading
ultrasound experts

Aritz, CEO of Resolve Stroke, is a seasoned professional with over 7 years of experience in Healthcare, Tech, and Private Equity support. Prior to founding Resolve Stroke, he was a valued member of the Roland Berger Healthcare global core team, a key strategy consulting firm. Aritz brings a unique blend of skills and knowledge to drive Resolve Stroke. Aritz’s expertise stems from his cross-disciplinary academic background, with degrees in Medical Sciences from Imperial College London, Business from HEC Paris, and Engineering from CentraleSupélec.

Vincent is a renouned expert in biomedical ultrasounds and a pioneer in software-driven ultrasound methods. He co-founded Resolve Stroke after close to ten years in world class laboratories including as a visiting researcher at Harvard University, USA, co-writing more than twenty papers and four patents. Vincent brings a solid technical expertise from his academic background and original engineering degree from ESPCI. He brings his experience of conducting clinical research and a solid network of clinicians.

CNRS Research Director, team leader at the Biomedical Imaging Laboratory (Sorbonne Université, CNRS, INSERM), Paris, France

Olivier Couture is a distinguished figure in the field of medical imaging and ultrasound technology. With a deep expertise in non-invasive diagnostic techniques, he has significantly contributed to advancing the accuracy and efficacy of ultrasound diagnostics with several scientific publications for instance in Nature.

Séverine, Clinical and Regulatory Director at Resolve Stroke, brings over 16 years of extensive experience in Healthcare and Clinical Research across diverse settings including hospitals, research institutes, and Contract Research Organizations (CROs). Her academic and professional journey has equipped her with a deep understanding of the intricacies of healthcare and regulatory environments. At Resolve Stroke, Séverine plays a pivotal role in refining the clinical and regulatory strategies. She is instrumental in supporting clinical studies, ensuring compliance with regulations, and fostering effective communication with authorities, ethics committees, and notified bodies. Her commitment to excellence and her comprehensive understanding of both clinical and regulatory domains make her an invaluable asset to the team.

VP engineering, Maxime supervises our technical developments. With over a decade of experience in the healthcare industry, Maxime’s expertise spans across various medical fields such as neurostimulation, cardiac resynchronization, and EEG monitoring. His exceptional leadership skills, honed during his tenure as the Hardware/Firmware Director at BioSerenity, are a valuable asset as we embark on our future endeavors. On the educational front, Maxime holds a degree in Mechanics from the renowned Ecole Polytechnique, and a degree in Material Science from Mines Paris – PSL. His wealth of experience and impressive academic credentials make him a crucial part of our team.

Maxence is a seasoned software engineer with experience spanning academia and industry, currently leading the software engineering at Resolve Stroke. In his academic journey, he studied engineering at CentraleSupelec, completed a PhD in Computer Science at Inria, and conducted research in computational geometry at UCLouvain. Post-academia, Maxence joined Siemens Digital Industries Software to contribute to their High-Performance Computing Multiphysics simulation software. At ResolveStroke, Maxence leverages his extensive scientific computing knowledge and industry experience to help the company achieve its ambitious goals.

Dr. Anthony Samir is a Professor at Harvard Medical School, and a Diagnostic and Interventional Radiologist at the Massachusetts General Hospital, where he serves as Service Chief for Body Ultrasound Imaging Services. He has an extensive clinical leadership experience in a high-volume service comprising 50 technologists at 10 sites read by ~110 radiologists. He is a serial inventor, with five inventor’s prizes for medical devices and multiple patents. With his internationally recognized expertise in quantitative biomarker development, medical devices, applied machine learning, ultrasound, cancer, liver disease, and thyroid disease, he is a key asset for Resolve Stroke. As Resolve Stroke’s advisor, he brings his extensive experience with technology transition to industry and with executing at multiple levels: entrepreneur, board roles.

Sylvain Bodard currently conducts clinical research at Memorial Sloan Kettering in New York and Harvard University in Boston, US. He is a Clinical Fellow at Necker Hospital, Paris Cité University in Paris, France. In this role, he performs and supervises scheduled and on-call image-guided interventional radiology procedures for both inpatients and outpatients. His responsibilities include patient triage and admission, as well as the protocol/readout of diagnostic x-ray, computed tomography, and magnetic resonance imaging studies. His previous research in France (Sorbonne University, CNRS, INSERM, LIB, SMAER, Paris) and today in the US focuses on advancing medical imaging techniques and furthering the understanding and treatment of various medical conditions.

MD. Clement Gakuba, coordinator at CHU de Caen Normandie, is a seasoned professional with over 7 years of experience in Anesthesiology and Intensive Care. He holds a critical role as a referring physician in surgical intensive care. His past experiences include being a postdoctoral researcher at Harvard Medical School and an associate researcher at Inserm. MD. Gakuba’s expertise stems from his diverse academic and professional background, with a Doctorate in Medicine and a Master’s degree in Medical Sciences from Inserm laboratory.

Denis Vivien, Professor and Research Director at Inserm and CHU de Caen Normandie, is an esteemed professional with a diverse background in molecular biology and neuroscience. He leads a team of 140 at Inserm, driving groundbreaking research on the central nervous system. Prior to establishing his lab, Vivien completed a postdoctoral position at the Sloan Kettering Cancer Center, further enriching his expertise. His unique blend of skills and knowledge has led to significant discoveries, particularly on the tissue plasminogen activator (tPA), which promises to revolutionize stroke treatment. His work has been recognized internationally, most notably with the 2023 Prix Danièle Hermann.

Vivien Szabo, Anesthesiologist and Researcher in the department of Anesthesiology and Critical Care Medicine at Montpellier University Hospital (France) combines his medical practice with cutting-edge research in neuroscience. After training at the medical school of Montpellier, he joined the Inserm Liliane Bettencourt School – MD-PhD program, where he mastered cellular biology and BRET microscopy. His doctoral studies in Serge Charpak’s laboratory led to significant advancements in simultaneous calcium imaging and photoactivation with cellular resolution. Now, as part of Julie Perroy’s team, he continues to develop innovative in vivo microscopy techniques to investigate physiological and pathological synaptic transmission. His unique blend of clinical practice and research makes him a valuable contributor to the field of neuroscience.

MD-PhD. Maxime Gauberti is an Interventional Neuroradiologist in the Department of Neuroradiolology at Caen-Normandie University Hospital. Alongside his clinical practice, he spent over 11 years as a Postdoctoral Fellow at INSERM Laboratory, contributing to advancements in neurosciences. MD. Gauberti has an extensive training in medical sciences, human anatomy, and physiology to diagnose and treat various medical conditions. His academic and professional journey illustrates his commitment to advancing healthcare through research and clinical practice.

Claude Cohen-Bacrie received the M.Sc. degree in engineering in signal and image processing from the ENSEA, France, in 1992, and the M.Sc. degree in biomedical sciences from Polytechnique Montreal, Canada, in 1994. After managing ultrasound research within Philips Research, NY, USA, he co-founded SuperSonic Imagine, Aix-en-Provence, France, in 2005, and acted as Executive Vice President, Chief Technology Officer, and Chief Operating Officer. In 2018, he founded E-Scopics, an innovative ultrasound company, which aims at democratizing elastography to healthcare professionals. Claude’s expertise and leadership are invaluable for Resolve Stroke, bringing a wealth of knowledge and experience in ultrasound technology and healthcare business development.

David, who co-founded Implicity with Arnaud Rosier in 2016, now serves as Chief Innovation Officer. Under his leadership, the company has developped innovative AI algorithms based on cardiac data. The company is now the European leader in telemonitoring of implantable cardiac devices and remote patient monitoring. In 2022, they raised a 21m euros Serie A. Aligned with Resolve Stroke’s ambition, David brings his visionary approach to data management in the healthcare industry.

Julien Gautier joined Roland Berger in 2006, where he has excelled in leading strategic planning missions, supporting product launches, enhancing operational and financial performance, and providing restructuring and pre- and post-merger support for acquisitions in the health and MedTech sectors. His expertise is valued by both public and private actors, contributing to various aspects of the industry. With over 15 years of professional experience as a consultant in the MedTech and Healthcare Industry, Julien’s advice is invaluable for Resolve Stroke.